State Medicaid Outpatient Drug Utilization and Spending, 2010

State-reported data tracks covered outpatient drugs paid for by Medicaid agencies since the program's inception. The U.S. Department of Health & Human Services provides this 2010 snapshot, which includes drug names, National Drug Codes, prescription counts, and reimbursement dollars. Information is reported by individual states for drugs under the Medicaid Drug Rebate Program.

Use Cases

• Analyze state-level prescription drug spending patterns based on reported reimbursement dollars.
• Compare utilization rates for specific drugs across states based on the number of prescriptions.
• Study the market penetration of pharmaceuticals in Medicaid programs based on National Drug Code identifiers.
• Investigate the relationship between drug names and reimbursement volumes for policy impact assessments.

Strengths

• Data is reported by states for a major federal healthcare program, suggesting an authoritative source.
• Includes key financial and volume metrics: dollars reimbursed and number of prescriptions.
• Covers a specific year (2010), providing a clear temporal snapshot.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale analysis.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by state Medicaid agencies for covered outpatient drugs under the Medicaid Drug Rebate Program.

Time Range

2010

Freshness

Last updated 2026-04-08 20:32:41.374484; freshness should be verified.

Geography

United States (state-level)